Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 439

1.

Mouse induced glioma-initiating cell models and therapeutic targets.

Kondo T.

Anticancer Agents Med Chem. 2010 Jul;10(6):471-80.

PMID:
20879984
2.

Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation.

Hide T, Takezaki T, Nakatani Y, Nakamura H, Kuratsu J, Kondo T.

Cancer Res. 2009 Oct 15;69(20):7953-9. doi: 10.1158/0008-5472.CAN-09-2006. Epub 2009 Oct 6.

3.
4.

Stem cell-like cancer cells in cancer cell lines.

Kondo T.

Cancer Biomark. 2007;3(4-5):245-50. Review.

PMID:
17917153
5.

Brain cancer stem-like cells.

Kondo T.

Eur J Cancer. 2006 Jun;42(9):1237-42. Epub 2006 May 2. Review.

PMID:
16632342
6.

NKX2.2 suppresses self-renewal of glioma-initiating cells.

Muraguchi T, Tanaka S, Yamada D, Tamase A, Nakada M, Nakamura H, Hoshii T, Ooshio T, Tadokoro Y, Naka K, Ino Y, Todo T, Kuratsu J, Saya H, Hamada J, Hirao A.

Cancer Res. 2011 Feb 1;71(3):1135-45. doi: 10.1158/0008-5472.CAN-10-2304. Epub 2010 Dec 17.

7.

Essential role of the Hedgehog signaling pathway in human glioma-initiating cells.

Takezaki T, Hide T, Takanaga H, Nakamura H, Kuratsu J, Kondo T.

Cancer Sci. 2011 Jul;102(7):1306-12. doi: 10.1111/j.1349-7006.2011.01943.x. Epub 2011 May 3.

8.

Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.

Lee JS, Gil JE, Kim JH, Kim TK, Jin X, Oh SY, Sohn YW, Jeon HM, Park HJ, Park JW, Shin YJ, Chung YG, Lee JB, You S, Kim H.

Biochem Biophys Res Commun. 2008 Jan 18;365(3):496-502. Epub 2007 Nov 20.

PMID:
18021740
9.

Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells.

Chi S, Kitanaka C, Noguchi K, Mochizuki T, Nagashima Y, Shirouzu M, Fujita H, Yoshida M, Chen W, Asai A, Himeno M, Yokoyama S, Kuchino Y.

Oncogene. 1999 Apr 1;18(13):2281-90.

10.

The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells.

Park HJ, Kim JK, Jeon HM, Oh SY, Kim SH, Nam DH, Kim H.

Mol Cells. 2010 Nov;30(5):403-8. doi: 10.1007/s10059-010-0122-z. Epub 2010 Aug 31. Erratum in: Mol Cells. 2011 Feb ;31(2):199. Park, Myung-Jin [removed]; Soeda, Akio [removed].

11.

Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres.

Méndez O, Zavadil J, Esencay M, Lukyanov Y, Santovasi D, Wang SC, Newcomb EW, Zagzag D.

Mol Cancer. 2010 Jun 1;9:133. doi: 10.1186/1476-4598-9-133.

12.

IGFBP2 promotes glioma tumor stem cell expansion and survival.

Hsieh D, Hsieh A, Stea B, Ellsworth R.

Biochem Biophys Res Commun. 2010 Jun 25;397(2):367-72. doi: 10.1016/j.bbrc.2010.05.145. Epub 2010 May 31.

PMID:
20515648
13.

Glioma stem cell signaling: therapeutic opportunities and challenges.

Dietrich J, Diamond EL, Kesari S.

Expert Rev Anticancer Ther. 2010 May;10(5):709-22. doi: 10.1586/era.09.190. Review.

PMID:
20470003
14.

Induction of autophagic cell death of glioma-initiating cells by cell-penetrating D-isomer peptides consisting of Pas and the p53 C-terminus.

Ueda Y, Wei FY, Hide T, Michiue H, Takayama K, Kaitsuka T, Nakamura H, Makino K, Kuratsu J, Futaki S, Tomizawa K.

Biomaterials. 2012 Dec;33(35):9061-9. doi: 10.1016/j.biomaterials.2012.09.003. Epub 2012 Sep 21.

PMID:
23006589
15.

Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.

Clément-Schatlo V, Marino D, Burkhardt K, Teta P, Leyvraz F, Schatlo B, Frank S, Schaller K, Castella V, Radovanovic I.

Neuro Oncol. 2012 Jun;14(6):720-35. doi: 10.1093/neuonc/nos084. Epub 2012 May 14. Retraction in: Neuro Oncol. 2014 Jun;16(6):889.

16.

Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy.

Zhuang W, Long L, Zheng B, Ji W, Yang N, Zhang Q, Liang Z.

Cancer Sci. 2012 Apr;103(4):684-90. doi: 10.1111/j.1349-7006.2011.02198.x. Epub 2012 Jan 30.

17.

Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.

Fukaya R, Ohta S, Yamaguchi M, Fujii H, Kawakami Y, Kawase T, Toda M.

Cancer Lett. 2010 May 28;291(2):150-7. doi: 10.1016/j.canlet.2009.10.010. Epub 2009 Nov 13.

PMID:
19913993
18.

Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling.

Chen Y, Wang Z, Dai X, Fei X, Shen Y, Zhang M, Wang A, Li X, Wang Z, Huang Q, Dong J.

Cancer Lett. 2015 Sep 1;365(2):174-81. doi: 10.1016/j.canlet.2015.05.026. Epub 2015 Jun 3.

PMID:
26049020
19.

Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.

Shiras A, Chettiar ST, Shepal V, Rajendran G, Prasad GR, Shastry P.

Stem Cells. 2007 Jun;25(6):1478-89. Epub 2007 Mar 1.

Supplemental Content

Support Center